Chembond Material Technologies Limited (CHEMBOND)

Loading page…

Chembond Material Technologies Limited (CHEMBOND) · mywealthgrid

About

Chembond Material Technologies Limited manufactures specialty chemicals for industrial applications within the Materials sector. With a market cap of ₹231 Cr and recent quarterly revenues around ₹60–72 Cr, the company operates as a small-to-mid-cap player in India's chemicals & petrochemicals industry.

Face value: ₹5

Market cap

₹238 Cr

P/E

16.3×

P/B

1.4×

Dividend yield

2.1%

ROE

ROCE

10.6%

Debt / equity

0.02

OPM

7.2%

EPS (TTM)

₹10.9

Book value

₹124.2

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Operating margin volatility: OPM ranged 2.97% to 8.98% in recent quarters, signaling inconsistent cost control or demand fluctuations

Low institutional investor interest: FII holds just 0.61% and DII below 1.62%, limiting analyst coverage and capital inflows

Weak profitability relative to capital deployed: ROE of 7.98% is low; verify expectations for specialty chemicals returns

Negative 1-year return of -3.56% despite consistent dividend payouts; stock near 52-week lows (₹106.72) after highs of ₹202.56

Generated analysis · source review pending

Growth drivers

Consolidated revenue stable around ₹71–72 Cr in recent quarters (Mar–Jun 2026); growth trajectory should be verified against sector demand trends

Operating margin peaked at 8.98% in Mar 2026; consistency of this performance level could expand earnings if sustained

Minimal debt (D/E 0.02) provides financial flexibility to invest in capacity or R&D; verify capital allocation plans

Dividend sustainability across six years of payouts suggests underlying cash generation; growth reinvestment trends should be confirmed

Generated analysis · source review pending

2,177 historical price candles were omitted because the exchange source has not been verified.

₹177.6-2.9%1Y

Quick read

rule-based

Pros

+Almost debt-free (debt/equity 0)
+Comfortable interest coverage of 46.5×
+Dividend payout of 34.3% of profit
+High promoter holding of 68.1% with no pledge

Cons

−Low return on equity of 9.3% (3-yr avg)
−Thin operating margin of 7.2%
−Profit declined 8.7% a year over the last 5 years
−Revenue shrank over the last 5 years (-1.8% a year)

Research score

Structured signal from quality, growth, valuation and momentum.

58/100

Business quality: 47
Growth

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	271	321	334	301	268	274	349	440	462	201	250
COGS	181	188	209	168	142	143	204	255	244	116	148
Gross profit	90	133	125	134	126	131	146	185	218	85	102
	79	116	103	108	116	113	128	151	169	72	84
	11	17	23	26	10	18	18	35	49	14	18
OPM %	4.2%	5.3%	6.8%	8.5%	3.7%	6.6%	5%	7.9%	10.7%	6.8%	7.2%
Depreciation	4	4	4	4	4	5	4	5	6	3	4
Interest	2	1	1	1	1	0	1	1	1	1	0
	189	18	11	4	3	15	8	5	17	9	1
Profit before tax	—	—	28	24	8	29	21	34	60	19	16
Tax	38	7	4	5	5	8	7	9	16	2	3
Tax %	—	—	15.6%	18.7%	61%	28.5%	31.9%	26.4%	26%	9.8%	16.9%
	157	4	24	20	3	20	14	25	44	18	13
PAT margin %	57.7%	1.1%	7.1%	6.6%	1.2%	7.4%	4%	5.6%	9.6%	8.7%	5.2%
EPS (₹)	—	—	—	—	1.4	15.1	10.4	18.4	33	13.1	9.6
EPS adjusted (₹)	116.8	14.4	16.4	12.9	1.4	15.1	10.4	18.4	33	13.1	9.6
	—	—	—	—	143.9%	14.9%	48.3%	16.3%	10.6%	13.4%	20.9%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	7	7	7	7	7	7	7	7	7	7	7
Reserves	200	202	242	255	—	286	297	315	355	149	160
Minority interest	—	—	2	4	—	1	1	1	1	0	—
	11	11	9	7	—	2	2	7	7	3	4
	72	79	66	50	—	58	54	71	78	43	48
Total equity & liabilities	289	298	325	322	—	354	361	402	447	202	219
	47	47	108	109	124	122	121	116	122	34	41
CWIP	2	2	1	2	—	0	1	12	13	8	2
Investments	65	92	76	58	—	73	75	65	92	78	70
	175	157	140	153	—	159	164	208	219	83	107
Total assets	289	298	325	322	—	354	361	402	447	202	219

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Speciality Chemical	207.93	8.72	202.21	41.92	160.29	5.44
Animal health	42.15	5.45

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	44.4%	47.1%	47.8%	41.7%	42%	47.3%	42.3%	41%
EBITDA margin %	8.5%	3.7%	6.6%	5%	7.9%	10.7%	6.8%	7.2%
EBIT margin %	7.1%	2.1%	5%	3.7%	6.8%	9.5%	5.4%	5.8%
PAT margin %	6.6%	1.2%	7.4%	4%	5.6%	9.6%	8.7%	5.2%
Working capital
Receivable days	110	—	111	94	95	95	72	77
Inventory days	54	—	75	61	49	50	51	49
Payable days	—	—	110	70	76	81	103	87
NWC days	—	—	76	84	68	64	20	39
Leverage
Current ratio	3.08	—	3.17	3.59	2.72	3.07	2.23	2.37
Debt to EBITDA	0.26	—	0.1	0.09	0.21	0.14	0.19	0.23
Debt to equity	0.03	—	0.01	0	0.02	0.02	0.02	0.02
Interest coverage	32.3	11.1	68.9	30.8	33.4	51.7	29	46.5
Asset turnover	0.94	—	0.78	0.97	1.1	1.03	1	1.14
Return ratios
Return on assets %	6.2%	—	5.8%	3.9%	6.2%	9.9%	8.7%	5.9%
Return on capital employed %	9.7%	—	9.8%	7%	11%	17.7%	7.1%	10.6%
Return on equity %	7.6%	—	7%	4.6%	7.7%	12.3%	11.2%	7.7%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	67.54%	67.55%	67.55%	67.56%	67.61%	67.63%	67.65%	67.65%	67.65%	67.72%	68.08%	68.11%
	0.59%	1.1%	0.94%	0.66%	0.69%	0.81%	0.61%	0.61%	0.61%	0.61%	0.61%	0.61%
	0.69%	0.99%	1.19%	1.22%	1.19%	1.26%	1.32%	1.14%	0.74%	0.74%	0.74%	1.62%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	31.18%	30.36%	30.32%	30.56%	30.51%	30.3%	30.42%	30.6%	31%	30.93%	30.57%	29.66%
No. of shareholders	—	—	—	—	—	—	—	—	13,168	12,670	12,107	11,458

Promoter holding up 0.57 percentage points since Sep 2023.

1 disclosure

Person	Deal	Shares	Value	Holding	Filed
Sameer V ShahPromoters	BuyMarket Purchase	4,000	₹6.79 L	12.64% → 12.67%	24 Oct 20257(2)

Disclosed under SEBI’s insider-trading regulations, which require a filing only above ₹10 lakh in a quarter — smaller dealings are in no disclosure. Holdings are the filer’s own percentages, not recomputed.

19 deals · 6 Oct 2021 – 7 Feb 2024

Date	Client	Type	Venue	Side	Quantity	Price	Value
7 Feb 2024	ZAKI ABBAS NASSER	Bulk	NSE	Sell	70,000	₹496.79	₹3.48 Cr
5 Jan 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	89,877	₹619.87	₹5.57 Cr
5 Jan 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	89,877	₹618.85	₹5.56 Cr
22 Dec 2023	SEETHA KUMARI	Bulk	NSE	Sell	69,242	₹550.26	₹3.81 Cr
6 Nov 2023	SEETHA KUMARI	Bulk	NSE	Buy	69,242	₹426.59	₹2.95 Cr
15 Jun 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	90,268	₹427.75	₹3.86 Cr
15 Jun 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	90,268	₹427.84	₹3.86 Cr
22 May 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	78,933	₹346.54	₹2.74 Cr
22 May 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	78,933	₹345.72	₹2.73 Cr
23 Jan 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	1,38,903	₹299.65	₹4.16 Cr

1–10 of 19

1 / 2

Mr. Sameer Vinod ShahExecutive Director-Chairperson-MD
Mrs. Rashmi GavliChief Financial Officer
Mr. Nirmal Vinod ShahNon-Executive - Non Independent Director
Mr. Jaywant Keshavrao TawadeExecutive Director
Bhadresh D. ShahGeneral Manager (Commercial)
Mr. Jayesh Prabhulal ShahNon-Executive - Independent Director
Mrs. Gorsi Atul ParekhNon-Executive - Independent Director
Mr. Mayank Pradyumna ShahNon-Executive - Independent Director
Mr. Kamal Dev TandonNon-Executive - Independent Director
Mrs. Suchita SinghCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Chembond Material Technologies Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Clarification regarding CRISIL rating rationale dated September 29, 20261 Oct 2026 · Credit Rating
Clarification on Price Movement11 Sept 2026 · General
The Exchange has sought clarification from Chembond Material Technologies Ltd on September 10, 2026 with reference to significant movement in price, in order to ensure that investors have ....10 Sept 2026 · Clarification
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raunaq Sameer Shah

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

12 announcementsExport CSV

17 Jul 2026, 3:51 pmCompany Update

Grant Of Stock Options Under Chembond Material Technologies Limited - Employee Stock Option Plan 2025

General PDF

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	44.4%	47.1%	47.8%	41.7%	42%	47.3%	42.3%	41%
EBITDA margin %	8.5%	3.7%	6.6%	5%	7.9%	10.7%	6.8%	7.2%
EBIT margin %	7.1%	2.1%	5%	3.7%	6.8%	9.5%	5.4%	5.8%
PAT margin %	6.6%	1.2%	7.4%	4%	5.6%	9.6%	8.7%	5.2%
Working capital
Receivable days	110	—	111	94	95	95	72	77
Inventory days	54	—	75	61	49	50	51	49
Payable days	—	—	110	70	76	81	103	87
NWC days	—	—	76	84	68	64	20	39
Leverage
Current ratio	3.08	—	3.17	3.59	2.72	3.07	2.23	2.37
Debt to EBITDA	0.26	—	0.1	0.09	0.21	0.14	0.19	0.23
Debt to equity	0.03	—	0.01	0	0.02	0.02	0.02	0.02
Interest coverage	32.3	11.1	68.9	30.8	33.4	51.7	29	46.5
Asset turnover	0.94	—	0.78	0.97	1.1	1.03	1	1.14
Return ratios
Return on assets %	6.2%	—	5.8%	3.9%	6.2%	9.9%	8.7%	5.9%
Return on capital employed %	9.7%	—	9.8%	7%	11%	17.7%	7.1%	10.6%
Return on equity %	7.6%	—	7%	4.6%	7.7%	12.3%	11.2%	7.7%

Date	Category	Subject	Filing
17 Jul 2026, 3:51 pm	Company Update General	Grant Of Stock Options Under Chembond Material Technologies Limited - Employee Stock Option Plan 2025	PDF
17 Jul 2026, 3:36 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
7 Jul 2026, 5:24 pm	Board Meeting	Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors Of The Company Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015	PDF
7 Jul 2026, 9:04 am	Company Update Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	PDF

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-27	5	-12	-12	25	-0	2	28	19	15
	52	-0	19	14	-11	-2	0	-22	-8	-10
	-24	-3	-4	-6	-2	-4	-2	-5	-9	-1
Net cash flow	1	—	—	—	12	-6	0	1	2	3
Free cash flow	-24	—	—	—	21	-4	-12	16	15	-6
CFO / Operating profit %	-236.8%	28.9%	-54.5%	-47.9%	137.6%	-0.1%	6.3%	56.1%	143.3%	81.8%

Chembond Material Technologies Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Credit ratings

21

1

1

Segment results

Compounded sales growth

Compounded profit growth

Return on equity

Animal Health · revenue

Chembond Material Technologies Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Insider dealing

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Ratio timeline

Not in the F&O segment

No fund holdings on record

Quarterly record

Insider dealing

Bulk & block deals

Board and management

Announcements

Annual reports

Credit ratings

Dividends21

Board meetings1

Stock splits1

Profit & loss

Balance sheet

Segment results

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Animal Health · revenue

21

1

1